paxilline has been researched along with Carcinoma, Non-Small Cell Lung in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Awanis, G; Banerjee, S; Elmeligy, A; Gavrilovic, J; Johnson, R; Raveenthiraraj, S; Sobolewski, A; Warren, D | 1 |
| Chang, Y; Ding, X; Li, M; Li, Y; Liu, B; Shen, H; Wang, Y; Xie, SM; Xing, L | 1 |
| Hu, X; Jiang, H; Li, W; Zhang, H | 1 |
| De Rycker, M; Hibbert, A; Kermorgant, S; Lachmann, S; Milanovic, M; Parker, PJ; Radtke, S; Rossé, C | 1 |
| Chen, CY; Chen, YC; Cheng, YW; Lee, H; Lee, MC; Wu, DW; Wu, JY; Wu, TC | 1 |
| Bi, H; Bi, Y; Gao, F; Han, Y; Wang, X | 1 |
| Blons, H; Cazes, A; Houllier, AM; Laurent-Puig, P; Le Corre, D; Pallier, K | 1 |
| Haga, H; Ishihara, S; Kawaguchi, H; Nakamura, H; Nishioka, T; Ohba, Y; Shirato, H; Tsuda, M; Tsutsumi, K; Yamazaki, R; Yasuda, M; Yazawa, N | 1 |
| Chen, CY; Cheng, YW; Lee, H; Wang, J; Wu, DW | 1 |
| Azzalis, LA; de Abreu, LC; Feder, D; Fonseca, FL; Junqueira, VB; Nogoceke, E; Valenti, VE | 1 |
| Li, H; Zuo, W | 1 |
| Donato, NJ; Johnson, FM; Saigal, B; Talpaz, M | 1 |
| Chen, LB; Chen, WC; Ewaniuk, DS; Griffin, JD; Li, JL; Pisick, E; Richards, W; Rollins, BJ; Salgia, R; Sattler, M; Shapiro, GI; Sugarbaker, DJ; Wang, YB | 1 |
| Garcia-Marin, LJ; Jensen, RT; Leyton, J; Moody, TW; Tapia, JA | 1 |
14 other study(ies) available for paxilline and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
HGF/c-Met/β1-integrin signalling axis induces tunneling nanotubes in A549 lung adenocarcinoma cells.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Hepatocyte Growth Factor; Humans; Integrins; Lung Neoplasms; Paxillin; Phosphatidylinositol 3-Kinases | 2023 |
ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Matrix Metalloproteinase 1; Mice, Inbred BALB C; Mice, Nude; Paxillin; Proto-Oncogene Proteins c-ets; Transcriptional Activation | 2020 |
Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137/PXN axis in non-small cell lung cancer.
Topics: 3' Untranslated Regions; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MicroRNAs; Neoplasm Invasiveness; Paxillin; RNA, Long Noncoding; Signal Transduction | 2018 |
ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Movement; Focal Adhesions; Glycogen Synthase Kinase 3; HeLa Cells; Hepatocyte Growth Factor; Humans; Lung Neoplasms; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Paxillin; Proto-Oncogene Proteins c-met | 2013 |
Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Dasatinib; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Paxillin; Phosphorylation; Pyrimidines; Thiazoles; Xenograft Model Antitumor Assays | 2014 |
miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Humans; Lung Neoplasms; MicroRNAs; Molecular Targeted Therapy; Neoplasm Invasiveness; Paxillin | 2014 |
No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.
Topics: Axons; Base Sequence; Carcinoma, Non-Small-Cell Lung; DNA Primers; Humans; Introns; Lung Neoplasms; Paxillin; Polymerase Chain Reaction | 2009 |
Increased motility and invasiveness in tumor cells that survive 10 Gy irradiation.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Focal Adhesion Kinase 1; Humans; Integrin beta1; Lung Neoplasms; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Paxillin; Radiation Dosage; Vinculin | 2009 |
Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Gene Knockdown Techniques; Humans; Lung Neoplasms; Male; MicroRNAs; Molecular Targeted Therapy; Neoplasm Invasiveness; Oncogene Proteins, Viral; Paxillin; Repressor Proteins; RNA, Messenger; Transcription, Genetic; Up-Regulation | 2010 |
Adhesion molecules affected by treatment of lung cancer cells with epidermal growth factor.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; beta Catenin; Cadherins; Carcinoma, Non-Small-Cell Lung; Catenins; Cell Adhesion Molecules; Cell Line, Tumor; Crk-Associated Substrate Protein; Delta Catenin; Epidermal Growth Factor; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Paxillin; rap1 GTP-Binding Proteins; Talin; Vinculin | 2011 |
[Relationship of the expression of CD44v6 and paxillin to the prognosis of non-small cell lung carcinoma].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules; Cytoskeletal Proteins; Female; Glycoproteins; Humans; Hyaluronan Receptors; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paxillin; Phosphoproteins; Prognosis | 2003 |
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Gentian Violet; Head and Neck Neoplasms; Humans; Immunoprecipitation; Inhibitory Concentration 50; Laminin; Lung Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Pyrimidines; Retinoblastoma Protein; S Phase; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors; Trypan Blue | 2005 |
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Topics: 3T3 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Adhesion Molecules; Cell Movement; Cytoskeletal Proteins; Gene Expression; Humans; Lung Neoplasms; Mice; Paxillin; Phosphoproteins; Recombinant Fusion Proteins; Tumor Cells, Cultured | 1999 |
Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Bombesin; Carcinoma, Non-Small-Cell Lung; Cell Division; Cytoskeletal Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gastrin-Releasing Peptide; Genistein; Humans; Lung Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Tyrosine | 2001 |